Equity
Total Liabilities & Equity
Boston Scientific Total Liabilities & Equity increased by 1.6% to $44.35B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.5%, from $40.14B to $44.35B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 7.3% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryLeverage
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 1, 2026
How to read this metric
Growth in this figure indicates the expansion of the company's asset base, funded by either borrowing or equity issuance.
Detailed definition
The sum of all liabilities and stockholders' equity, which must equal total assets by definition. This represents the to...
Peer comparison
Used as the denominator for various asset-based efficiency ratios across the industry.
Metric ID:
total_liabilities_and_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $31.17B | $31.88B | $32.23B | $32.34B | $32.19B | $31.95B | $32.47B | $32.89B | $33.6B | $34.04B | $35.14B | $36.67B | $37.11B | $38.08B | $39.4B | $40.14B | $41.56B | $42.71B | $43.67B | $44.35B |
| QoQ Change | — | +2.3% | +1.1% | +0.3% | -0.5% | -0.8% | +1.6% | +1.3% | +2.2% | +1.3% | +3.2% | +4.4% | +1.2% | +2.6% | +3.5% | +1.9% | +3.5% | +2.8% | +2.3% | +1.6% |
| YoY Change | — | — | — | — | +3.3% | +0.2% | +0.7% | +1.7% | +4.4% | +6.6% | +8.2% | +11.5% | +10.4% | +11.9% | +12.1% | +9.5% | +12.0% | +12.2% | +10.9% | +10.5% |
Range$31.17B – $44.35B
CAGR+7.7%
Avg YoY Growth+7.9%
Median YoY Growth+10.0%
Current Streak14 quarters growth
Total Liabilities & Equity at Other Companies
Frequently Asked Questions
- What is Boston Scientific's total liabilities & equity?
- Boston Scientific (BSX) reported total liabilities & equity of $44.35B in Q1 2026.
- How has Boston Scientific's total liabilities & equity changed year-over-year?
- Boston Scientific's total liabilities & equity increased by 10.5% year-over-year, from $40.14B to $44.35B.
- What is the long-term trend for Boston Scientific's total liabilities & equity?
- Over 5 years (2020 to 2025), Boston Scientific's total liabilities & equity has grown at a 7.3% compound annual growth rate (CAGR), from $30.78B to $43.67B.
- What does total liabilities & equity mean?
- The total value of all company assets, funded by either debt or equity.